Abstract
Temporomandibular disorder (TMD) is a heterogeneous chronic systemic disease based on genetic, immunological, anatomical, morphological, and functional disorders of the articulatory norm. The task of the diagnostic stage is to identify direct (inherent in only one nosological form) and indirect (occurring in two or more nosological forms) etiological risks that transform into pathogenetic factors and TMDs. The transformation of the pathogenetic horizon of TMDs does characterize by the implementation of a scenario leading to the formation of three nosological forms of the disease: articular and nonarticular lesions of TMJ, and TMDs of iatrogenic etiology. TMDs of iatrogenic etiology constitute the most severe group of patients. Failure to identify biological, technological, and communication iatrogenic risks at the diagnostic stage is the main reason for triggering TMDs of iatrogenic etiology. The transformation of iatrogenic risks into iatrogenic pathogenetic factors leads to the formation of iatrogenic disease. A specialist working with this group of patients must have the necessary competence to make clinical decisions in the diagnosis, treatment, and rehabilitation of patients of this profile, including maxillofacial surgery and psychological counseling. Timely diagnosis of iatrogenic risks is the only preventive measure that prevents the development of iatrogenic TMDs. The therapy of TMDs of iatrogenic etiology does base on an interdisciplinary approach’s principles.
Reference55 articles.
1. Schiffman EL, Ahmad M, Hollender L, Kartha K, Ohrbach R, Truelove EL, et al. Longitudinal stability of common TMJ structural disorders. Journal of Dental Research. 2017;96(3):270-276. DOI: 10.1177/0022034516679396
2. Manfredini D, Lombardo L, Siciliani GJ. Temporomandibular disorders and dental occlusion. A systematic review of association studies: End of an era? Oral Rehabilitation. 2017;44(11):908-923
3. Murphy MK, MacBarb RF, Wong ME, Athanasiou KA. Temporomandibular disorders: A review of etiology, clinical management, and tissue engineering strategies. The International Journal of Oral & Maxillofacial Implants. 2013;28(6):e393-e414. DOI: 10.11607/jomi.te20
4. Carlsson GE. Epidemiology and treatment need for temporomandibular disorders. Journal of Orofacial Pain. 1999;13(4):232-237
5. Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. American Family Physician. 2015;91(6):378-386